Multi-Classification of Breast Cancer Lesions in Histopathological Images Using DEEPPachi: Multiple Self-Attention Head

INTRODUCTION AND BACKGROUND: Despite fast developments in the medical field, histological diagnosis is still regarded as the benchmark in cancer diagnosis. However, the input image feature extraction that is used to determine the severity of cancer at various magnifications is harrowing since manual procedures are biased, time consuming, labor intensive, and error-prone. Current state-of-the-art deep learning approaches for breast histopathology image classification take features from entire images (generic features). Thus, they are likely to overlook the essential image features for the unnecessary features, resulting in an incorrect diagnosis of breast histopathology imaging and leading to mortality. METHODS: This discrepancy prompted us to develop DEEPPachi for classifying breast histopathology images at various magnifications. The suggested DEEPPachi collects global and regional features that are essential for effective breast histopathology image classification. The proposed model backbone is an ensemble of DenseNet201 and VGG16 architecture. The ensemble model extracts global features (generic image information), whereas DEEPPachi extracts spatial information (regions of interest). Statistically, the evaluation of the proposed model was performed on publicly available dataset: BreakHis and ICIAR 2018 Challenge datasets. RESULTS: A detailed evaluation of the proposed model's accuracy, sensitivity, precision, specificity, and f1-score metrics revealed the usefulness of the backbone model and the DEEPPachi model for image classifying. The suggested technique outperformed state-of-the-art classifiers, achieving an accuracy of 1. 0 for the benign class and 0. 99 for the malignant class in all magnifications of BreakHis datasets and an accuracy of 1. 0 on the ICIAR 2018 Challenge dataset. CONCLUSIONS: The acquired findings were significantly resilient and proved helpful for the suggested system to assist experts at big medical institutions, resulting in early breast cancer diagnosis and a reduction in the death rate.